![[Translate to English:]](/fileadmin/_processed_/0/7/csm_laboratory-g3b6abbea5_1920_ec6c67f46a.jpg "[Translate to English:]")
Rare lung cancer treatment: new insights into molecular risk factor and tumor microenvironment
News from the Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Cystic fibrosis & COPD: Mucus reprograms immune cells and promotes airway inflammation
DZL researchers of the Translational Lung Research Center Heidelberg (TLRC) have discovered a new link between excessive airway mucus and chronic…
20 Years Lung Biobank Heidelberg - The success story of one of the largest lung tumor biobanks in Germany
The lung biobank at the Thoraxklinik at Heidelberg University Hospital (UKDH), partner in the German Center for Lung Research e.V. (DZL), celebrates…
Between research and clinic - DZL junior reserach group leader Prof. Frederik Trinkmann
Since 2020, Prof. Dr. Frederik Trinkmann has been leading the DZL-junior research group “Obstructive lung diseases” at the Translational Lung Research…
First DZL Academy Symposium – Virtual exchange between early career lung researchers
From 29-30 September 2021, the DZL Academy hosted their first symposium entitled "When bugs hit the lung - infections as drivers of acute…
Pulmonary fibrosis – novel imaging technique to visualize active scarring processes
TLRC researchers are developing imaging techniques to improve visualization of pulmonary fibrosis. In a study published in the Journal of Nuclear…
First symposium of the DZL 3.0 single cell genomics working group
Great interest at the online meeting with top international researchers
Uncovering the secrets of the lung microbiome – An interview with DZL - Junior Group leader Dr. Sébastien Boutin
We interviewed Dr. Sébastien Boutin on the lung microbiome, his ongoing lung research projects and how research on the microbiome can be translated…